Systemic Metabolic Signatures of Oral Diseases.

Humans Prospective Studies Triglycerides Fatty Acids Cholesterol Lipoproteins, LDL Inflammation Glycoproteins Pyruvates
dental caries endodontics inflammation metabolomics periodontitis root canal treatment

Journal

Journal of dental research
ISSN: 1544-0591
Titre abrégé: J Dent Res
Pays: United States
ID NLM: 0354343

Informations de publication

Date de publication:
01 2024
Historique:
medline: 22 12 2023
pubmed: 16 11 2023
entrez: 16 11 2023
Statut: ppublish

Résumé

Systemic metabolic signatures of oral diseases have been rarely investigated, and prospective studies do not exist. We analyzed whether signs of current or past infectious/inflammatory oral diseases are associated with circulating metabolites. Two study populations were included: the population-based Health-2000 (

Identifiants

DOI: 10.1177/00220345231203562 PMID: 37968796 PMC: PMC10734208
pubmed: 37968796
doi: 10.1177/00220345231203562
pmc: PMC10734208
doi:

Substances chimiques

Triglycerides 0
Fatty Acids 0
Cholesterol 97C5T2UQ7J
Lipoproteins, LDL 0
Glycoproteins 0
Pyruvates 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

13-21

Déclaration de conflit d'intérêts

Declaration of Conflicting InterestsThe authors declared no potential conflicts of interest with respect to the research, authorship, and/or publication of this article.

Références

Front Cardiovasc Med. 2022 Oct 04;9:993633
pubmed: 36267630
Clin Chim Acta. 2017 Aug;471:158-163
pubmed: 28579141
Nat Commun. 2023 Feb 3;14(1):604
pubmed: 36737450
Curr Opin Lipidol. 2000 Oct;11(5):451-6
pubmed: 11048887
Circulation. 2015 Mar 3;131(9):774-85
pubmed: 25573147
Eur Heart J. 2003 Dec;24(23):2099-107
pubmed: 14643270
J Endod. 2019 Feb;45(2):111-115
pubmed: 30711165
J Dent Res. 2020 Sep;99(10):1165-1173
pubmed: 32479136
Eur J Oral Sci. 2018 Oct;126 Suppl 1:26-36
pubmed: 30178551
Int J Prosthodont. 2007 Mar-Apr;20(2):161-7
pubmed: 17455437
Genome Biol. 2017 Aug 1;18(1):146
pubmed: 28764798
Clin Oral Investig. 2022 Jan;26(1):993-1001
pubmed: 34313848
Metabolomics. 2022 Oct 25;18(11):83
pubmed: 36282436
PLoS Med. 2014 Feb 25;11(2):e1001606
pubmed: 24586121
Dent Clin North Am. 2015 Oct;59(4):859-72
pubmed: 26427571
Am J Epidemiol. 2017 Nov 1;186(9):1084-1096
pubmed: 29106475
Oral Dis. 2017 Jul;23(5):576-597
pubmed: 27426637
Innate Immun. 2021 Jan;27(1):3-14
pubmed: 33243051
J Intern Med. 2012 Dec;272(6):562-72
pubmed: 22650159
Cell Syst. 2015 Oct 28;1(4):293-301
pubmed: 27136058
Sci Rep. 2019 May 23;9(1):7764
pubmed: 31123322
Nature. 2020 Dec;588(7836):135-140
pubmed: 33177712
J Lipid Res. 2004 Jul;45(7):1169-96
pubmed: 15102878
Nutrients. 2023 Jun 05;15(11):
pubmed: 37299601
Periodontol 2000. 2017 Oct;75(1):317-329
pubmed: 28758299
Periodontol 2000. 2022 Jun;89(1):142-153
pubmed: 35244953
Int Endod J. 2021 May;54(5):672-681
pubmed: 33275782
Lancet. 2023 Apr 15;401(10384):1293-1301
pubmed: 36893777
J Periodontal Res. 2018 Oct;53(5):894-901
pubmed: 29974463
PLoS One. 2014 Aug 18;9(8):e105181
pubmed: 25133529
BMC Oral Health. 2021 Sep 25;21(1):472
pubmed: 34563194
J Transl Med. 2017 Oct 27;15(1):219
pubmed: 29078787
JAMA Netw Open. 2019 Apr 5;2(4):e192523
pubmed: 31026022
J Lipid Res. 2004 Jan;45(1):139-47
pubmed: 13130123

Auteurs

A Salminen (A)

Oral and Maxillofacial diseases, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
ORCID: 0000-0001-7576-090X

A M Määttä (AM)

Oral and Maxillofacial diseases, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

P Mäntylä (P)

Institute of Dentistry, University of Eastern Finland, Kuopio, Finland.
Odontology Education, Kuopio University Hospital, Kuopio, Finland.

J Leskelä (J)

Oral and Maxillofacial diseases, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
ORCID: 0000-0001-9670-339X

M Pietiäinen (M)

Oral and Maxillofacial diseases, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

K Buhlin (K)

Oral and Maxillofacial diseases, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Division of Periodontology, Department of Dental Medicine, Karolinska Institutet, Huddinge, Sweden.

A L Suominen (AL)

Institute of Dentistry, University of Eastern Finland, Kuopio, Finland.
Odontology Education, Kuopio University Hospital, Kuopio, Finland.
Department of Public Health and Welfare, National Institute for Health and Welfare, Helsinki, Finland.

S Paju (S)

Oral and Maxillofacial diseases, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.

W Sattler (W)

Division of Molecular Biology and Biochemistry, Gottfried Schatz Research Center, Medical University of Graz, Graz, Austria.

J Sinisalo (J)

HUCH Heart and Lung Center, Helsinki University Hospital and University of Helsinki, Finland.

P J Pussinen (PJ)

Oral and Maxillofacial diseases, University of Helsinki and Helsinki University Hospital, Helsinki, Finland.
Institute of Dentistry, University of Eastern Finland, Kuopio, Finland.
ORCID: 0000-0003-3563-1876

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Systemic Metabolic Signatures of Oral Diseases.
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Caractéristiques des études épidémiologiques › Études épidémiologiques › Études de cohortes › Études prospectives › Systemic Metabolic Signatures of Oral Diseases.
questionsmedicales.fr › Lipides › Glycérides › Triglycéride › Systemic Metabolic Signatures of Oral Diseases.
questionsmedicales.fr › Lipides › Acides gras › Systemic Metabolic Signatures of Oral Diseases.
questionsmedicales.fr › Lipides › Lipides membranaires › Stérols › Cholestérol › Systemic Metabolic Signatures of Oral Diseases.
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Lipoprotéines › Lipoprotéines LDL › Systemic Metabolic Signatures of Oral Diseases.
questionsmedicales.fr › États, signes et symptômes pathologiques › Processus pathologiques › Inflammation › Systemic Metabolic Signatures of Oral Diseases.
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Glycoprotéines › Systemic Metabolic Signatures of Oral Diseases.
questionsmedicales.fr › Composés chimiques organiques › Acides carboxyliques › Cétoacides › Pyruvates › Systemic Metabolic Signatures of Oral Diseases.